NCT03273140

The Effectiveness of Gamification Diabetes Education Program for Poorly Controlled Type 2 Diabetic Patients

Completed NA Last updated 22 August 2018

What this trial tests

NA trial testing Gamification Diabetes Education Program (GDEP) in Diabetic Patients, Gamification, Diabetic Education in 158 participants. Completed in 15 August 2018.

Timeline

1 March 2017

Primary endpoint
15 August 2018

15 August 2018

Quick facts

Lead sponsor	National Healthcare Group, Singapore
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	158
Start date	1 March 2017
Primary completion	15 August 2018
Estimated completion	15 August 2018
Sites	1 location across Singapore

Drugs / interventions tested

• Gamification Diabetes Education Program (GDEP)

Conditions studied

• Diabetic Patients, Gamification, Diabetic Education — all drugs for Diabetic Patients, Gamification, Diabetic Education →

Sponsor

National Healthcare Group, Singapore

Who can join

Adults 21 to 75, any sex, with Diabetic Patients, Gamification, Diabetic Education. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: The prevalence of DM is increasing across both Asian and Western countries, in proportion to the rising aging population. Type 2 diabetic patients are the high-risk group to experience diabetes-related complications that can lead to depression, poor quality of life and even death. In the current face-to-face diabetes counseling, the patients presented with weak comprehension of diabetes knowledge. There is a gap between application of knowledge and self-efficacy behaviors. With the increased patient acuity in the recent years, it has contributed to the shortage of diabetes nurse educators to meet the demands or needs in the outpatient endocrine clinic. Often, the patients have to wait longer for their turn for diabetes education, which can result in a delay in diabetes self-management. The use of mobile health technologies had demonstrated a positive impact on diabetes-related outcomes and better self-efficacy behaviors, all of which are crucial in diabetes management.

Aims: This study is to evaluate the effectiveness of Gamification Diabetes Education Program (GDEP) on HbA1c values, self-efficacy, sense of coherence and quality of life among the poorly controlled 2 diabetic patients.

Methods: This study adopted a randomized control trial design. Based on Cohen's power analysis, one hundred and forty-eight participants will be recruited through simple random sampling. The recruitment process includes block randomization and allocation concealment. Participants will either be randomized into intervention (GDEP) group or control (current practice) group. The self-efficacy instrument, sense of coherence scale (SOC-13), world health organisation quality of life scale- brief (WHOQoL-BREF) and HbA1c values assessed the outcomes at the same time points: point of enrollment (pre) and two post-time points at 12-week and 24-week.

The significance of study: GDEP would bring about awareness on diabetes management and contribute to existing diabetes literature. It addresses the clinical significance of enhancing diabetes knowledge and motivation in self-efficacy behaviors. Hence, GDEP has the potential to close the gap between application of knowledge to self-efficacy behaviors, which in turn would result in better self-efficacy, sense of coherence and quality of life. All of these could reduce their HbA1c values and the global health care expenditure spent on managing diabetes mellitus alone. The development of GDEP is a value-added and innovative-driven packaging to close the gap and address the limitation in the current literature. It serves to transform workforce and redesign patient education process for type 2 diabetic patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.